Menu Search
Equities

China Health Technology Group Holding Company Ltd

CHBOF:PKC

China Health Technology Group Holding Company Ltd

Actions
  • Price (USD)0.002
  • Today's Change0.00 / 0.00%
  • Shares traded22.35m
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Oct 29 2024 13:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

China Health Technology Group Holding Co Ltd, formerly China Bozza Development Holdings Ltd, is a company principally engaged in the forestry management and ginseng business. The Company’s forestry management business is mainly engaged in the sales of timber logs harvested from forests. The Company’s ginseng business is mainly engaged in the planting and sales of compound hybridisation breed with traditional wild ginseng grown in the north or cold regions and other different varieties of ginseng. The Company mainly conducts businesses within the domestic market.

  • Revenue in HKD (TTM)51.26m
  • Net income in HKD215.35m
  • Incorporated2009
  • Employees33.00
  • Location
    China Health Technology Group Holding Company LtdRoom 4009, 40F, Rongchao Trading CentrNo. 4028 Jintian RoadFutian DistrictSHENZHEN ChinaCHN
  • Phone+86 75 582793080
  • Fax+86 75 582552379
  • Websitehttp://www.01069.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.